30021200 - Antisera, other blood - EU Trade

Extra-EU sourcing of Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes, Antisera and other blood fractions is highly concentrated. 🇺🇸 United States captures 73.7% of imports (€25.7B), followed by 🇨🇭 Switzerland (19.1%). With an HHI of 5804, this Concentrated market exposes the EU to supply dependency risks.

The main extra-EU export markets for Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes, Antisera and other blood fractions are 🇺🇸 United States, 🇨🇭 Switzerland, 🇶🇿 QZ. 🇺🇸 United States absorbs 30.6% of European exports (€17.3B).

Within the EU, 🇩🇪 Germany concentrates 43.8% of Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes, Antisera and other blood fractions imports, well ahead of 🇦🇹 Austria (21.7%). The top importing member states are 🇩🇪 Germany, 🇦🇹 Austria, 🇪🇸 Spain.

In 2025, imports were declining (-7.3%) and exports declining (-12.5%) compared to the previous year.

Frequently Asked Questions

Who is the main supplier of Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes, Antisera and other blood fractions to the EU?

The main extra-EU supplier of Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes, Antisera and other blood fractions (NC8 30021200) is 🇺🇸 United States, accounting for 73.7% of European imports over the period Jan 2022-Mar 2026.

What is the EU trade balance for Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes, Antisera and other blood fractions?

The extra-EU trade balance for Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes, Antisera and other blood fractions (NC8 30021200) is €21.6B over the period Jan 2022-Mar 2026 (imports: €34.8B, exports: €56.5B).

How much does the EU import of Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes, Antisera and other blood fractions?

The EU imported €34.8B of Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes, Antisera and other blood fractions (NC8 30021200) from third countries between Jan 2022 and Mar 2026, representing 124.0M kg in volume.

What is the average import price per kg of Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes, Antisera and other blood fractions?

The weighted average import price of Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes, Antisera and other blood fractions (NC8 30021200) is €281.07/kg over the period Jan 2022-Mar 2026.

Which EU member state imports the most Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes, Antisera and other blood fractions?

The leading EU member state importer of Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes, Antisera and other blood fractions (NC8 30021200) is 🇩🇪 Germany, accounting for 43.8% of EU imports.

In 2025, imports were declining (-7.3%) and exports declining (-12.5%) compared to the previous year.

1	🇺🇸 United States	€25.7B	73.7%	102.8M kg
2	🇨🇭 Switzerland	€6.6B	19.1%	3.9M kg
3	🇬🇧 United Kingdom	€691.3M	2.0%	6.7M kg
4	🇮🇱 Israel	€407.2M	1.2%	103K kg
5	🇦🇺 Australia	€368.7M	1.1%	816K kg
6	🇪🇬 Egypt	€94.4M	0.3%	555K kg

#	Country	Value (EUR)	Share (%)	Weight (kg)
1	🇺🇸 United States	€17.3B	30.6%	6.1M kg
2	🇨🇭 Switzerland	€13.5B	23.9%	16.5M kg
3	🇶🇿 QZ	€5.2B	9.1%	751K kg
4	🇨🇳 China	€4.9B	8.7%	19.3M kg
5	🇬🇧 United Kingdom	€2.3B	4.1%	3.4M kg

#	Partner	Value (EUR)	kg	€/kg	Share
1	🇺🇸 United States	€25.7B	102.8Mt	€249.91/kg	75.8%
2	🇨🇭 Switzerland	€6.6B	3.9Mt	€1.7K/kg	19.6%
3	🇬🇧 United Kingdom	€691.3M	6.7Mt	€103.07/kg	2.0%
4	🇮🇱 Israel	€407.2M	103Kt	€4.0K/kg	1.2%
5	🇦🇺 Australia	€368.7M	816Kt	€451.55/kg	1.1%
6	🇪🇬 Egypt	€94.4M	555Kt	€169.97/kg	0.3%

#	Partner	Value (EUR)	kg	€/kg	Share
1	🇺🇸 United States	€17.3B	6.1Mt	€2.8K/kg	40.1%
2	🇨🇭 Switzerland	€13.5B	16.5Mt	€820.09/kg	31.2%
3	🇶🇿 QZ	€5.2B	751Kt	€6.9K/kg	11.9%
4	🇨🇳 China	€4.9B	19.3Mt	€254.40/kg	11.4%
5	🇬🇧 United Kingdom	€2.3B	3.4Mt	€695.01/kg	5.4%

#	Partner	Value (EUR)	kg	€/kg	Share
1	🇺🇸 United States	€25.7B	102.8Mt	€249.91/kg	75.8%
2	🇨🇭 Switzerland	€6.6B	3.9Mt	€1.7K/kg	19.6%
3	🇬🇧 United Kingdom	€691.3M	6.7Mt	€103.07/kg	2.0%
4	🇮🇱 Israel	€407.2M	103Kt	€4.0K/kg	1.2%
5	🇦🇺 Australia	€368.7M	816Kt	€451.55/kg	1.1%
6	🇪🇬 Egypt	€94.4M	555Kt	€169.97/kg	0.3%

EU External Trade - Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes, Antisera and other blood fractions

Analysis

Trade Partners

Import Partners (Top 10)

Frequently Asked Questions

Analysis

Trade Partners

Import Partners (Top 10)

Export Partners (Top 10)

Interactive Charts

Trade value (2022–2025)

Import sources

Export markets

EU Member States

Trade value (2022–2025)

Import sources

Export markets

EU Member States

EU External Trade - Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes, Antisera and other blood fractions

Frequently Asked Questions

Related Pages

Export Partners (Top 10)

Interactive Charts

Trade value (2022–2025)

Import sources

Export markets

EU Member States

Trade value (2022–2025)

Import sources

Export markets

EU Member States